Form D · Biotechnology
Precise Bio, Inc.
Winston Salem, NC · CIK 0001904090
Offering snapshot reported Jan 17, 2024 · SEC filing
- Reported sold
- $12M Offering amount: $25M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $75K Reported outside-investor minimum
- First sale
- Jul 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2024 | Initial | $12,000,000 | No comparison | 8 | SEC filing |
| Feb 9, 2022 | Initial | $15,530,000 | No comparison | 70 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $75K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-502616
Commissions are in form of warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Michael Avruch | None |
Source: Form D, filed Jan 17, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Atala | Director, Promoter |
| Aryeh Batt | Director, Executive, Promoter |
| Nathan Cali | Director |
| Viko Dana | Director |
| Yalon Farhi | Director |
| Ori Hadimi | Director, Executive |
| Avi Katz | Director |
| Ilan Lior | Director |
| Dirk Muehlhoff | Director |
| Shay Soker | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
111 North Chestnut Street, Suite 103
Winston Salem, NC, 27101-4054
Winston Salem, NC, 27101-4054